Related references
Note: Only part of the references are listed.Discovery and Investigation of 1-[4-(2-Aminoethoxy)Phenylcarbonyl]-3,5-Bis-(Benzylidene)-4-Piperidones as Candidate Antineoplastic Agents: Our Last 15 Years Study
Mohammad Hossain et al.
CURRENT MEDICINAL CHEMISTRY (2021)
VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines
Nami Kurozumi et al.
CANCER SCIENCE (2021)
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky et al.
INVESTIGATIONAL NEW DRUGS (2020)
Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs
Jennifer A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
Paola Pellegrini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity
Vasty Osei-Amponsa et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
Dienone Compounds: Targets and Pharmacological Responses
Martina Bazzaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Current status and new treatment approaches in TP53 mutated AML
Anthony M. Hunter et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation
Ellin-Kristina Hillert et al.
CANCER LETTERS (2019)
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Karthik Selvaraju et al.
SCIENTIFIC REPORTS (2019)
Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
Arjan Mofers et al.
PLOS ONE (2019)
Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins
Mohammad Hossain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53
Esha Madan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones
Lisett Contreras et al.
CELLULAR ONCOLOGY (2018)
Bioactivities of EF24, a Novel Curcumin Analog: A Review
Yonghan He et al.
FRONTIERS IN ONCOLOGY (2018)
The Essential Medicinal Chemistry of Curcumin
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition
Chun-Yu Liu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
A high-throughput AO/PI-based cell concentration and viability detection method using the Celigo image cytometry
Leo Li-Ying Chan et al.
CYTOTECHNOLOGY (2016)
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
Jonathan B. Baell
JOURNAL OF NATURAL PRODUCTS (2016)
Molecular targets of curcumin for cancer therapy: an updated review
Pandima Devi Kasi et al.
TUMOR BIOLOGY (2016)
The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
Xin Wang et al.
SCIENTIFIC REPORTS (2016)
EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma
Da-long Yin et al.
SCIENTIFIC REPORTS (2016)
Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b-AP15
Xin Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Synthesis, Characterization, and Optimization for in Vivo Delivery of a Nonselective Isopeptidase Inhibitor as New Antineoplastic Agent
Ulma Cersosimo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
Ellen Weisberg et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Induction of Tumor Cell Apoptosis by a Proteasome Deubiquitinase Inhibitor Is Associated with Oxidative Stress
Slavica Brnjic et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Quantitative wPhenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation
Beibei Zhang et al.
PLOS ONE (2014)
A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer
Ravi K. Anchoori et al.
CANCER CELL (2013)
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells
Shanshan Pei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
Haitao Liu et al.
PLOS ONE (2012)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Reactivation of p53: from peptides to small molecules
Christopher J. Brown et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model
Ines J. Marques et al.
BMC CANCER (2009)
Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms
Karen Bernard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype
Krzysztof Mrozek
SEMINARS IN ONCOLOGY (2008)
The unfolded protein response - A stress signaling pathway critical for health and disease
KZ Zhang et al.
NEUROLOGY (2006)
EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
BK Adams et al.
ANTI-CANCER DRUGS (2005)
ESOL: Estimating aqueous solubility directly from molecular structure
JS Delaney
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
The development of proteasome inhibitors as anticancer drugs
J Adams
CANCER CELL (2004)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines
DS Fleckenstein et al.
LEUKEMIA RESEARCH (2002)